Current Affairs Topics Archive
International Relations Economics Polity & Governance Environment & Ecology Science & Technology Internal Security Geography Social Issues Art & Culture Modern History

India-US tariffs after Supreme Court verdict: An explainer


What Happened

  • Following the US Supreme Court's February 20, 2026 ruling in Learning Resources, Inc. v. Trump striking down IEEPA-based tariffs, India's tariff situation with the US shifted significantly.
  • India will face a flat 10% reciprocal tariff (later raised to 15%) under Trump's new global tariff executive order, which invokes Section 232 and Section 301 authorities instead of IEEPA.
  • This is substantially lower than the earlier IEEPA-based 50% tariff on Indian goods that had been in place before the India-US interim trade framework was agreed in early February 2026.
  • The India-US interim trade framework (announced February 2026) remains on track: India will face 18% tariff on most goods, while specific sectors — pharmaceuticals, gems and diamonds, smartphones — receive zero-duty access to the US.
  • Trump affirmed the India-US deal is unchanged post-ruling, stating India will pay tariffs to the US while the US will not pay tariffs to India, reflecting a reciprocal structure.

Static Topic Bridges

India-US Bilateral Trade Agreement (BTA) and Interim Framework

India and the United States agreed in early February 2026 on a framework for an Interim Agreement as a precursor to a full Bilateral Trade Agreement (BTA). The two countries had launched BTA negotiations in February 2025. The interim framework aims to rebalance trade by reducing US tariffs on Indian goods and Indian tariffs on US goods, with a particular focus on ending reciprocal tariff escalation.

  • US applies 18% reciprocal tariff on most Indian goods (down from earlier IEEPA-level 50%) under the interim framework
  • Zero-duty on Indian exports: generic pharmaceuticals, gems and diamonds, smartphones, aircraft parts, select agricultural products, handicrafts, tea and coffee
  • India's commitments: eliminate or reduce tariffs on all US industrial goods and a wide range of agricultural products; sensitive sectors (dairy, rice, millets) protected
  • India commits to purchase $500 billion worth of US energy, aircraft, precious metals, technology products, and coking coal over 5 years
  • Interim Agreement expected to be signed by March 2026; will act as a bridge to the full BTA

Connection to this news: The Supreme Court's IEEPA ruling does not invalidate the India-US deal — the deal was negotiated within the framework of the President's surviving trade authorities and bilateral diplomacy, not under IEEPA.

WTO Framework and Preferential Trade Agreements

India's trade relationship with the US operates at the intersection of WTO multilateral rules and bilateral preferential arrangements. The WTO framework (General Agreement on Tariffs and Trade — GATT, 1994, and the Marrakesh Agreement, 1994) establishes Most Favoured Nation (MFN) obligations, meaning a tariff reduction granted to one country generally must be extended to all WTO members, unless covered by a Free Trade Agreement (FTA) or other recognized exception under GATT Article XXIV.

  • WTO established: January 1, 1995 (replacing GATT 1947); India is a founding member
  • MFN principle (GATT Article I): Non-discriminatory tariff treatment to all WTO members
  • GATT Article XXIV: Permits FTAs/Customs Unions that are WTO-compatible if they cover "substantially all trade" and do not raise barriers against third countries
  • GATT Article XXI: National security exception — allows tariffs on national security grounds (basis for US Section 232 tariffs)
  • India-US trade (2024-25): Total bilateral trade approximately $190 billion; India's trade surplus with the US around $45 billion
  • Dispute Mechanism: WTO Dispute Settlement Body (DSB) — India has challenged US Section 232 copper tariffs as effectively being safeguard measures without WTO notification

Connection to this news: Any India-US interim trade deal must eventually be made WTO-compatible (through formal FTA notification) or face challenges from third countries — a key compliance challenge as negotiations move toward the full BTA.

Trade Deficit and India's Export Structure

A trade deficit occurs when a country's imports exceed its exports. The US-India trade relationship is marked by India running a consistent trade surplus with the US — the main political driver behind US tariff pressure. India's key exports to the US include pharmaceuticals, IT/software services, gems and jewellery, engineering goods, and apparel. Under the interim framework, zero-duty access for pharmaceuticals (which account for ~$8 billion of Indian exports) and gems is particularly significant.

  • India's goods trade surplus with the US (2024-25): approximately $45 billion
  • India's top goods exports to US: pharmaceuticals (~$8 bn), gems and jewellery (~$10 bn), engineering goods, apparel
  • India's imports from US: aircraft, defence equipment, oil and gas, high-tech machinery, agricultural products (soybeans, almonds)
  • Indian pharmaceutical exports: ~30% of US generic drug market by volume — zero-duty access is critical for affordability
  • CACP (Commission for Agricultural Costs and Prices): India's mechanism to protect domestic agriculture; dairy, rice, millets are politically sensitive and protected in the deal

Connection to this news: The interim deal's zero-duty basket (pharma, gems, smartphones) targets India's highest-value and highest-volume export categories, making the deal economically significant even before the full BTA is signed.

Key Facts & Data

  • India faces 10%–15% flat global tariff post-IEEPA ruling (under new executive order)
  • India-US interim framework tariff on most Indian goods: 18% (down from IEEPA-era 50%)
  • Zero-duty Indian exports to US under deal: pharmaceuticals, gems, diamonds, smartphones, aircraft parts
  • India's bilateral trade with US (2024-25): approximately $190 billion total
  • India's trade surplus with US: approximately $45 billion
  • India's pharmaceutical exports to US: approximately $8 billion per year; ~30% of US generic market by volume
  • India's $500 billion US energy/technology purchase commitment: over 5 years
  • Full BTA (Bilateral Trade Agreement) target: following the interim agreement signed by March 2026
  • WTO founding: January 1, 1995; India a founding member; 166 current members